Cefoxitin

CAT:
804-HY-B1825-01
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Cefoxitin - image 1

Cefoxitin

  • Description:

    Cefoxitin is a cephalosporin-class antibiotic. Cefoxitin is highly stable against β-Lactamase (HY-P2998) . Cefoxitin has a broad spectrum of antibacterial activity, including Gram-negative and Gram-positive bacteria[1][2][3].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H317, H334
  • Target:

    Antibiotic; Bacterial; Beta-lactamase
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection
  • Assay Protocol:

    https://www.medchemexpress.com/cefoxitin.html
  • Concentration:

    10mM
  • Purity:

    99.92
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@@](NC(CC3=CC=CS3)=O)(OC)C1=O)O
  • Molecular Formula:

    C16H17N3O7S2
  • Molecular Weight:

    427.45
  • Precautions:

    H317, H334
  • References & Citations:

    [1]E O Stapley, et al. Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis. Jan-Feb 1979;1 (1) :73-89.|[2]R N Brogden, et al. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979 Jan;17 (1) :1-37.|[3]Venkata Raveendra Pothineni, et al. In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease. Drug Des Devel Ther. 2018; 12: 2915–2921.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture and light)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Citation 01:

    Antimicrob Agents Chemother. 2025 May 23:e0024925.|bioRxiv. 2025 Jun 19.|Diagn Microbiol Infect Dis. 2025 Nov 4;114 (2) :117181.|Infect Drug Resist. 2025 Oct 4:18:5239-5247.|J Antimicrob Chemother. 2025 Nov 5:dkaf408.|J Clin Microbiol. 2025 Aug 20:e0084125.|Microbiol Spectr. 2025 May 19:e0307424.|Nat Commun. 2022 Mar 2;13 (1) :1116.|Nat Commun. 2023 Mar 22;14 (1) :1594.|Nat Microbiol. 2023 Mar;8 (3) :410-423.|J Antimicrob Chemother. 2020 Jul 1;75 (7) :1850-1858.
  • CAS Number:

    35607-66-0